1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA

DRWKF
Drägerwerk AG & Co. KGaAUS flagOther OTC
100.47
USD
- -
- -
1.88BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
143.15
144.44
148.11
142.11
144.83
146.12
156.58
184.59
177.42
162.33
179.82
179.75
185.82
182.64
Basic EPS, GAAP
7.26
6.2
1.87
4.62
5.55
1.93
1.88
13.56
8.22
-3.44
5.89
6.63
7.44
5.43
Free Cash Flow per Basic Share
-1.39
4.87
-4.23
6.51
4.09
-3.25
5.63
18.7
14.63
-12.32
6.47
5.52
8.41
6.64
Dividend per Share
1.32
1.18
1.96
0.23
0.23
0.62
0.23
0.3
0.22
0.2
0.2
1.77
2
2.04
Book Value per Share
38.27
39.54
38.16
41.01
46.53
47.04
46.43
41.43
51.87
54.23
59.66
65.72
73.34
65.95
Tangible Book Value per Share
32.14
35.74
33.73
36.93
40.87
41.93
41.8
38.09
48.31
51.64
56.69
63.67
68.98
61.19
Basic Weighted Avg Shares
17
17
18
18
18
18
18
18
19
19
19
19
19
18
Sales/Revenue/Turnover
2,374
2,435
2,609
2,524
2,572
2,595
2,781
3,406
3,328
3,045
3,374
3,371
3,482
3,361
Operating Margin (%)
8.73
7.28
3.07
6.12
5.95
2.47
2.97
12.09
8.34
-2.62
5.46
5.34
6.65
4.27
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
120
105
33
82
99
34
33
250
154
-65
110
124
139
100
Effective Tax Rate (%)
32.4
31.84
32.78
32.66
31.08
32.44
31.77
30.62
34.81
- -
20.75
28.87
34.91
29.29
Profit Margin (%)
5.07
4.29
1.26
3.25
3.83
1.32
1.2
7.34
4.63
-2.12
3.27
3.69
4.01
2.97
Working Capital
670
703
585
723
728
753
763
994
1,057
684
848
906
970
745
LT Debt
260
178
147
198
146
132
200
239
270
242
340
287
293
234
Total Equity
816
897
946
1,004
1,068
1,081
1,076
1,034
1,260
1,319
1,409
1,537
1,629
1,466
Return on Invested Capital (%)
11.67
9.82
4.14
7.78
7.81
3.17
4.09
20.16
11.64
- -
7.89
6.48
7.38
5.21
Return on Capital (%)
14.54
12.59
4.77
9.65
10.81
4.17
4.33
24.74
14.66
- -
8.98
8.89
9.19
6.55
Return on Common Equity (%)
20.61
16.07
4.93
11.72
12.68
4.13
4.02
31.48
17.75
-6.49
10.34
10.58
10.7
8.48

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
109
115
213
LT Borrowings
204
154
154
LT Finance Leases
83
- -
79
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
863
989
1,050

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,885
1,852
1,756
Cash, Cash Equivalents & STI
248
291
219
Accounts Receivable, Net
788
630
623
Inventories
654
713
706
Total Current Liabilities
978
1,021
1,011
Payables & Accruals
- -
- -
- -
ST Debt
109
115
213
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.78%
9.69%
5.98%
Free Cash Flow
-81.99%
-63.93%
52.28%
Net Income, GAAP
32.43%
-85.3%
12.13%
Sales/Revenue/Turnover
3.24%
0.64%
3.29%
Total Cash Common Dividend
- -
- -
13.01%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
736
785
775
1,076
3,371
2025
730
780
1,138
- -
3,482
2026
756
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.37
1.42
0.77
- -
6.63
2025
-0.12
0.6
- -
- -
7.44
2026
0.6
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
1.77
- -
- -
1.77
2025
- -
2
- -
- -
2
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Stefan A. Drager
Full Time Employees
15,444
Sector
Healthcare
Industry
Medical - Devices
Address
Moislinger Allee 53-55 Lübeck SH Germany 23558
IPO Date
Aug 3, 2012
Website
draeger.com
Similar Companies
Demant A/S (WILLF)
Semler Scientific, Inc. (SMLR)
ALR Technologies Inc. (ALRT)
ProSomnus, Inc. (OSAAW)
Artivion, Inc. (AORT)
E-Qure Corp. (EQUR)
Business
Drägerwerk AG & Co. KGaA develops, manufactures and markets medical and safety technology products worldwide, operating through two primary divisions focused on acute care solutions and hazard management systems. Founded in 1889 and headquartered in Lübeck, Germany, the family-owned company employs over 16,000 people, maintains sales and service subsidiaries in approximately 50 countries, and distributes its products across more than 190 countries with 18 development and production sites. In fiscal year 2024, it generated net sales of EUR 3.4 billion while investing EUR 331.1 million in research and development, launching 24 new products. The medical division offers anaesthesia workstations such as the Atlan series; ventilators including the Evita and Babylog models for intensive, emergency and neonatal care; patient monitoring systems; ceiling supply units; IT solutions for operating theatres; gas management systems; warming therapy devices like Babyroo; and related services including maintenance, repairs, financing models and consumables. The safety division provides respiratory protection equipment including powered air-purifying respirators like Dräger X-plore 8700, self-contained breathing apparatus such as Dräger BG ProAir, and professional diving rebreathers; stationary and portable gas detection systems like Dräger X-am 8000 multi-gas detectors and colorimetric detector tubes; alcohol and drug testing devices including interlocks; thermal imaging cameras such as Dräger UCF FireCore; and customized fire training facilities, programs and hazard management solutions for industries including mining, oil and gas, chemicals, fire services and emergency response. Dräger serves hospitals, fire departments, emergency services, mining operations and industrial sectors with a focus on expanding service, consumables and after-sales contracts leveraging its installed base. Recent developments include consolidating neonatal care operations into a single Lübeck facility to enhance efficiency and reduce fixed costs; achieving record order intake of EUR 1.7 billion and positive operating cash flow of EUR 18 million in the first half of 2025 amid stable net sales growth; strong demand and earnings performance in the first nine months of 2025; and the October 2024 divestiture of its measurement technology unit Dräger MSI GmbH to Rems Messtechnik GmbH & Co KG following the cessation of safety business in Russia due to geopolitical sanctions.